These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Substance use disorders: a theory-driven approach to the integration of genetics and neuroimaging. Karoly HC, Harlaar N, Hutchison KE. Ann N Y Acad Sci; 2013 Apr; 1282():71-91. PubMed ID: 23470155 [Abstract] [Full Text] [Related]
9. Toluene abuse causing reduced MR signal intensity in the brain. Caldemeyer KS, Pascuzzi RM, Moran CC, Smith RR. AJR Am J Roentgenol; 1993 Dec; 161(6):1259-61. PubMed ID: 8249738 [No Abstract] [Full Text] [Related]
10. The brain in the belly: what and how of fetal neuroimaging? Girard NJ, Chaumoitre K. J Magn Reson Imaging; 2012 Oct; 36(4):788-804. PubMed ID: 22987757 [Abstract] [Full Text] [Related]
12. Structural neuroimaging in aging and Alzheimer's disease. Vernooij MW, Smits M. Neuroimaging Clin N Am; 2012 Feb; 22(1):33-55, vii-viii. PubMed ID: 22284732 [Abstract] [Full Text] [Related]
13. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W. Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607 [Abstract] [Full Text] [Related]
14. Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches. Gardner TJ, Kosten TR. Am J Drug Alcohol Abuse; 2007 Nov; 33(6):765-7. PubMed ID: 17994472 [No Abstract] [Full Text] [Related]
20. [The cerebral perivascular spaces: review of the literature on diffuse or focal expansion]. Conforti R, Marrone V, Sardaro A, Di Maio N, Manzi F, Rossi M, Amato M, Giganti M, Genovese EA. Recenti Prog Med; 2013 Nov; 104(7-8):291-4. PubMed ID: 24042394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]